Improving management and outcomes of the Boston type 1 keratoprosthesis: lessons learned from available evidence

摘要: Boston Keratoprosthesis type I (KPro) surgery is a relatively novel treatment for severe corneal blindness in the context of recurrent graft failure and high-risk conditions such as cicatrizing disease, aniridia, herpetic keratitis or chemical burns. Recently, modifications design, surgical techniques postoperative management have increased success rate popularity KPro. Complication rates decreased substantially last decade making KPro safe therapeutic alternative to certain pathologies. However, comorbidities glaucoma late-onset fungal infections remain problem. This article will review recent evidence about outcomes I.